| 2D Structure | |
| CID | 135398641 |
| IUPAC Name | 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one |
| InChI | InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1 |
| InChI Key | UGQMRVRMYYASKQ-KQYNXXCUSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C10H12N4O5 |
| Molecular Weight | 268.23 |
| synonyms | ['inosine', '58-63-9', 'Hypoxanthosine', 'Ribonosine', 'Atorel', 'Oxiamin', 'Hypoxanthine riboside', 'Trophicardyl', 'Selfer', 'Hypoxanthine D-riboside', '9-beta-D-Ribofuranosylhypoxanthine', 'Hypoxanthine ribonucleoside', 'Hypoxanthine nucleoside', 'Inosina', 'Inosinum', 'Inotin', 'INO 495', 'DTXSID2045993', '5A614L51CT', 'NSC-20262', '9-beta-D-ribofuranosyl-9H-purin-6-ol', 'DTXCID0025993', 'CHEBI:17596', '9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one', '9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one', '9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one', '9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1H-purin-6-one', '9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-1H-purin-6-one', '9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-3H-purin-6-one', 'RefChem:791048', 'D06BB05', 'G01AX02', 'S01XA10', '9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H-purin-6-one', '200-390-4', 'Panholic-L', 'Pantholic-L', '(-)-Inosine', 'Inosie', 'iso-prinosine', 'Inosine [INN:JAN]', 'Inosinum [INN-Latin]', 'Inosina [INN-Spanish]', 'hypoxanthine-ribose', 'INO', 'MFCD00066770', 'Hypoxanthine, 9-beta-D-ribofuranosyl-', 'Inosin', 'AI3-52241', 'HXR', 'Hypoxanthine-9-beta-D-ribofuranoside', 'NSC 20262', 'beta-D-Ribofuranoside, hypoxanthine-9', 'Hypoxanthine 9-beta-D-ribofuranoside', 'MLS000028518', '9.beta.-D-Ribofuranosylhypoxanthine', '1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one', '9-.beta.-D-Ribofuranosylhypoxanthine', 'SMR000058316', '9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one', '.beta.-Inosine', '9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one', 'CAS-58-63-9', 'SR-01000721862', 'EINECS 200-390-4', 'Carnine', 'Catacol', 'Hypoxanthosine;', 'NSC20262', 'Trophicardyl;', 'UNII-5A614L51CT', 'Oxiamine;', '3h-inosine', 'D-Inosine', 'Inosie;', '2ada', '2fqw', '.beta.-D-Ribofuranoside, hypoxanthine-9', 'NCGC00095787-01', 'Adenosine Imp. G (EP); Inosine; Didanosine Imp. B (Ph. Int.); 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one; Adenosine Impurity G; Didanosine Impurity B', 'Hypoxanthine, 9-.beta.-D-ribofuranosyl-', 'Inotin (TN)', 'Hypoxanthine riboside;', 'CID 5274258', 'Inosine (JAN/INN)', '1a4m', 'Inosine (8CI,9CI)', 'INOSINE [INN]', 'INOSINE [JAN]', 'INOSINE [MI]', 'INOSINE [MART.]', 'Opera_ID_1628', 'INOSINE [WHO-DD]', 'INOSINE [WHO-IP]', 'bmse000098', 'bmse000888', 'bmse000978', 'cid_6021', 'CHEMBL1556', 'SCHEMBL15804', 'KBioGR_002560', 'KBioSS_002569', 'INOSINE [USP IMPURITY]', 'GTPL4554', 'orb3025449', 'SCHEMBL1682742', 'SCHEMBL3365586', 'SCHEMBL6933022', '9-b-D-Ribofuranosylhypoxanthine', 'Hypoxanthine-9-D-ribofuranoside', 'Inosine, >=99% (HPLC)', 'SCHEMBL18653532', '9beta-D-Ribofuranosylhypoxanthine', 'BDBM22104', 'KBio2_002560', 'KBio2_005128', 'KBio2_007696', 'KBio3_003038', '9-|A-D-Ribofuranosylhypoxanthine', '9-b-D-ribofuranosyl-Hypoxanthine', 'MSK6812', '9-|_-D-Ribofuranosylhypoxanthine', 'cMAP_000084', 'HMS2235I17', 'Hypoxanthine-9-delta-ribofuranoside', '9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one (Inosine)', '9-beta-D-ribofuranosyl-Hypoxanthine', 'HY-N0092', '9beta-delta-Ribofuranosylhypoxanthine', 'Tox21_111522', 'BDBM50366815', 'beta-D-Ribofuranoside hypoxanthine-9', 'EBC-44242', 'EBC-47437', 'hypoxanthine-9 beta-D-Ribofuranoside', 'MFCD22689457', 's2442', '9-beta-delta-Ribofuranosylhypoxanthine', '(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxypurin-9-yl)oxolane-3,4-diol', 'AKOS015969695', 'AKOS015995607', 'AKOS024462561', 'Atorel; HXR; Hypoxanthine D-riboside', 'Tox21_111522_1', '9-beta-delta-ribofuranosyl-Hypoxanthine', 'CCG-267127', 'CS-5845', 'DB04335', 'DIDANOSINE IMPURITY B [WHO-IP]', 'NI06297', '9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one', 'beta-delta-Ribofuranoside hypoxanthine-9', 'Hypoxanthine 9-beta-delta-ribofuranoside', 'hypoxanthine-9 beta-delta-Ribofuranoside', 'Hypoxanthine-9-beta-delta-ribofuranoside', 'SMP1_000165', 'NCGC00095787-05', 'NCGC00095787-06', 'NCGC00096119-02', 'NCGC00096119-03', 'AS-11754', 'BP-51105', 'SY005000', '9-(beta-D-ribofuranosyl)-9H-purin-6-ol', 'ADENOSINE IMPURITY G [EP IMPURITY]', 'DB-029916', 'DIDANOSINE IMPURITY B [EP IMPURITY]', 'I0037', 'NS00010210', 'C00294', 'D00054', 'EN300-310328', '1,9-dihydro-9-b-D-ribofuranosyl-6H-Purin-6-one', 'Q422564', 'SR-01000721862-2', 'SR-01000721862-3', 'AC89F8E4-FD89-45EE-8B41-94DFC07AB42F', 'BRD-K79612754-001-19-1', 'BRD-K79612754-001-21-7', '1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one', '6H-Purin-6-one, 1,9-dihydro-9-beta-D-ribofuranosyl-', 'Z2681890654', 'Inosine; Adenosine EP Impurity G; Didanosine EP Impurity B', '9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE', '9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]', '(2R,3R,4S,5R)-2-(6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol', '(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-3,4-diol', '9-(3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1,9-DIHYDRO-PURIN-6-ONE', '9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one', '478182-32-0', '9-|A-D-Ribofuranosylhypoxanthine; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one', 'InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s'] |
From Pubchem